Compared with the IUGR group, dietary supplementation with 200 mg/kg of curcumin significantly decreased mRNA expression of TNFα, IL-6, and IFNγ, and increased mRNA expression of IL-2 in jejunal mucosa (p < 0.05). The gene discussed is IL2; the disease is fetal growth restriction.